Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Neurocrine Biosciences, Inc.”

110 pharma patents match "Neurocrine Biosciences, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 110
Index total 30,257
Page 3 / 5

Quick answer

This filtered view shows 110 pharmaceutical patents matching "Neurocrine Biosciences, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

110 results for “Neurocrine Biosciences, Inc.” · 30,257 patents in full index Clear search

  1. US 8481731

    Compounds, pharmaceutical composition and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  2. US 8357697

    Substituted 3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-A]isoquinolin-2-ol compounds and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Jan 22, 2013 · Expires Jan 17, 2033

    granted

  3. US 8293729

    Compounds, pharmaceutical composition and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Oct 23, 2012 · Expires Oct 18, 2032

    granted

  4. US 8263588

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted

  5. US 8084614

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Dec 27, 2011 · Expires Dec 22, 2031

    granted

  6. US 8039627

    Substituted 3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-A]isoquinolin-2-ol compounds and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted

  7. US 7652035

    CRF receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Jan 26, 2010 · Expires Jan 21, 2030

    granted

  8. US 7462625

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Dec 9, 2008 · Expires Dec 4, 2028

    granted

  9. US 7459458

    Polymorph of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto

    Neurocrine Biosciences, Inc. · Granted Dec 2, 2008 · Expires Nov 27, 2028

    granted

  10. US 7427630

    Condensed N-heterocyclic compounds and their use as CRF receptor antagonists

    Neurocrine Biosciences, Inc. · Granted Sep 23, 2008 · Expires Sep 18, 2028

    granted

  11. US 7419983

    Gonadotropin-releasing hormone receptor antagonists and methods related thereto

    Neurocrine Biosciences, Inc. · Granted Sep 2, 2008 · Expires Aug 28, 2028

    granted

  12. US 7378552

    Monoamine re-uptake inhibitors and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted May 27, 2008 · Expires May 22, 2028

    granted

  13. US 7329669

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Feb 12, 2008 · Expires Feb 7, 2028

    granted

  14. US 7304069

    Hydrate of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5α]-pyrimidin-7-yl}phenyl)acetamide and processes and methods related thereto

    Neurocrine Biosciences, Inc. · Granted Dec 4, 2007 · Expires Nov 29, 2027

    granted

  15. US 7229995

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Jun 12, 2007 · Expires Jun 7, 2027

    granted

  16. US 7179815

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Feb 20, 2007 · Expires Feb 15, 2027

    granted

  17. US 7176211

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Feb 13, 2007 · Expires Feb 8, 2027

    granted

  18. US 7081459

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Jul 25, 2006 · Expires Jul 20, 2026

    granted

  19. US 7071200

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Jul 4, 2006 · Expires Jun 29, 2026

    granted

  20. US 7056927

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Jun 6, 2006 · Expires Jun 1, 2026

    granted

  21. US 7034118

    Corticotropin-releasing factor2 receptors

    Neurocrine Biosciences, Inc. · Granted Apr 25, 2006 · Expires Apr 20, 2026

    expired

  22. US 7015226

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Mar 21, 2006 · Expires Mar 16, 2026

    expired

  23. US 6958342

    Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto

    Neurocrine Biosciences, Inc. · Granted Oct 25, 2005 · Expires Oct 20, 2025

    expired

  24. US 6951858

    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

    Neurocrine Biosciences, Inc. · Granted Oct 4, 2005 · Expires Sep 29, 2025

    expired

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.